---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-083248"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2025-08-27T23:59:59+00:00"
generated_at: "2026-05-17T09:44:05.621371+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Quoin finalizes CFO exit: $433K lieu of notice, $108K bonus, extended options

## Summary
- Separation agreement signed August 21; effective August 15, 2025.
- Dunn receives $433,620 in bi-weekly installments in lieu of 12 months' notice.
- Additional $108,405 bonus for FY2024 paid in lump sum after 12 months.
- Vested stock options post-termination exercise period extended to 1 year 9 months from 90 days.
- Agreement includes mutual release of claims; no admission of liability.

## SEC filing metadata
- accession: 0001104659-25-083248
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2025-08-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465925083248/0001104659-25-083248-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925083248/tm2524439d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-083248
- JSON: https://secwatch.observer/filing/0001104659-25-083248.json
- Plain text: https://secwatch.observer/filing/0001104659-25-083248.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.